Follow
Anita Langerød
Anita Langerød
Researcher, Oslo University Hospital
Verified email at rr-research.no
Title
Cited by
Cited by
Year
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
62122012
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
22932016
Mutational processes molding the genomes of 21 breast cancers
S Nik-Zainal, LB Alexandrov, DC Wedge, P Van Loo, CD Greenman, ...
Cell 149 (5), 979-993, 2012
21302012
The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
19422012
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1887*2020
The life history of 21 breast cancers
S Nik-Zainal, P Van Loo, DC Wedge, LB Alexandrov, CD Greenman, ...
Cell 149 (5), 994-1007, 2012
16012012
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
T Hung, Y Wang, MF Lin, AK Koegel, Y Kotake, GD Grant, HM Horlings, ...
Nature genetics 43 (7), 621-629, 2011
13842011
Complex landscapes of somatic rearrangement in human breast cancer genomes
PJ Stephens, DJ McBride, ML Lin, I Varela, ED Pleasance, JT Simpson, ...
Nature 462 (7276), 1005-1010, 2009
10212009
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
WA Freed-Pastor, H Mizuno, X Zhao, A Langerød, SH Moon, ...
Cell 148 (1), 244-258, 2012
9162012
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
H Zhao, A Langerød, Y Ji, KW Nowels, JM Nesland, R Tibshirani, ...
Molecular biology of the cell 15 (6), 2523-2536, 2004
4952004
TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer
A Langerød, H Zhao, Ø Borgan, JM Nesland, IRK Bukholm, T Ikdahl, ...
Breast cancer research 9, 1-16, 2007
3692007
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
L Silwal-Pandit, HKM Vollan, SF Chin, OM Rueda, S McKinney, T Osako, ...
Clinical Cancer Research 20 (13), 3569-3580, 2014
3282014
Mutation of GATA3 in human breast tumors
J Usary, V Llaca, G Karaca, S Presswala, M Karaca, X He, A Langerød, ...
Oncogene 23 (46), 7669-7678, 2004
3192004
p53 polymorphism and risk of cervical cancer
A Storey, M Thomas, A Kalita, C Harwood, D Gardiol, F Mantovani, ...
Nature 396 (6711), 532-532, 1998
2251998
Oslo Breast Cancer Consortium (OSBREAC). The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
1912012
TP53 mutations in breast and ovarian cancer
L Silwal-Pandit, A Langerød, AL Børresen-Dale
Cold Spring Harbor perspectives in medicine 7 (1), a026252, 2017
1762017
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
HG Russnes, HKM Vollan, OC Lingjærde, A Krasnitz, P Lundin, B Naume, ...
Science translational medicine 2 (38), 38ra47-38ra47, 2010
1762010
Discovery and validation of breast cancer subtypes
AV Kapp, SS Jeffrey, A Langerød, AL Børresen-Dale, W Han, DY Noh, ...
BMC genomics 7, 1-15, 2006
1712006
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
AM Pietersen, HM Horlings, M Hauptmann, A Langerød, A Ajouaou, ...
Breast Cancer Research 10, 1-12, 2008
1642008
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
A Langerød, IRK Bukholm, A Bregard, PE Lønning, TI Andersen, ...
Cancer Epidemiology Biomarkers & Prevention 11 (12), 1684-1688, 2002
1602002
The system can't perform the operation now. Try again later.
Articles 1–20